These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30636056)

  • 21. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody.
    Ionescu DN; Girnita AL; Zeevi A; Duquesnoy R; Pilewski J; Johnson B; Studer S; McCurry KR; Yousem SA
    Transpl Immunol; 2005 Oct; 15(1):63-8. PubMed ID: 16223674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection.
    Tower CM; Reyes M; Nelson K; Leca N; Kieran N; Muczynski K; Jefferson JA; Blosser C; Kukla A; Maurer D; Chandler W; Najafian B
    Transplantation; 2017 Sep; 101(9):2235-2243. PubMed ID: 27846156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts.
    Arias LF; Fernández R; Fernández D; Jaramillo JC; Gil M; López García-Asenjo JA
    Transplant Proc; 2010 Jun; 42(5):1793-6. PubMed ID: 20620525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.
    Luk A; Alba AC; Butany J; Tinckam K; Delgado D; Ross HJ
    Transpl Int; 2015 Jul; 28(7):857-63. PubMed ID: 25778989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy.
    Moseley EL; Atkinson C; Sharples LD; Wallwork J; Goddard MJ
    J Heart Lung Transplant; 2010 Apr; 29(4):417-23. PubMed ID: 20188594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsies.
    Papadimitriou JC; Drachenberg CB; Ramos E; Kukuruga D; Klassen DK; Ugarte R; Nogueira J; Cangro C; Weir MR; Haririan A
    Transplantation; 2013 Jan; 95(1):128-36. PubMed ID: 23222897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
    Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A
    Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.
    Haas M; Segev DL; Racusen LC; Bagnasco SM; Locke JE; Warren DS; Simpkins CE; Lepley D; King KE; Kraus ES; Montgomery RA
    J Am Soc Nephrol; 2009 Jan; 20(1):197-204. PubMed ID: 18776120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive C4d in kidney transplantation biopsy: clinical impact.
    Pedraza N; Girón F; Baez Y; Niño A; Rodriguez J; Orozco C
    Transplant Proc; 2014 Nov; 46(9):2966-71. PubMed ID: 25420802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.
    O'Leary JG; Kaneku H; Demetris AJ; Marr JD; Shiller SM; Susskind BM; Tillery GW; Terasaki PI; Klintmalm GB
    Liver Transpl; 2014 Feb; 20(2):218-27. PubMed ID: 24382837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of antibody-mediated rejection in cardiac transplantation: a call for standardization.
    Tan CD; Rodriguez ER
    Curr Opin Organ Transplant; 2010 Dec; 15(6):769-73. PubMed ID: 20881496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?
    Boffini M; Ricci D; Bonato R; Ribezzo M; Simonato E; Saviolo R; Checco L; Comoglio C; Rinaldi M
    Transplant Proc; 2011 May; 43(4):1168-70. PubMed ID: 21620080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of different staining techniques for c4d detection in renal allograft biopsies.
    Ludovico-Martins H; Silva C; Teodoro WR; Martini Filho D; Noronha IL
    Transplant Proc; 2009 Apr; 41(3):862-5. PubMed ID: 19376373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
    Frank R; Molina MR; Goldberg LR; Wald JW; Kamoun M; Lal P
    Am J Clin Pathol; 2014 Dec; 142(6):809-15. PubMed ID: 25389335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-mediated rejection in pediatric small bowel transplantation: Capillaritis is a major determinant of C4d positivity in intestinal transplant biopsies.
    Rabant M; Racapé M; Petit LM; Taupin JL; Aubert O; Bruneau J; Barbet P; Goulet O; Chardot C; Suberbielle C; Lacaille F; Canioni D; Duong Van Huyen JP
    Am J Transplant; 2018 Sep; 18(9):2250-2260. PubMed ID: 29397036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.
    Choi J; Cho YM; Yang WS; Park TJ; Chang JW; Park SK
    Clin Transplant; 2007; 21(2):159-65. PubMed ID: 17425739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does asymptomatic recurrent diffuse capillary C4d complement deposition impair cardiac allograft function?
    Frea S; Iacovino C; Botta M; De Filippi I; Mazzucco G; Pidello S; Biolè C; Bergerone S; Boffini M; Praticò Barbato L; Morello M; Rinaldi M; Gaita F
    Clin Transplant; 2016 Oct; 30(10):1314-1323. PubMed ID: 27490635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts.
    Kozlowski T; Andreoni K; Schmitz J; Hayashi PH; Nickeleit V
    Liver Transpl; 2012 Jun; 18(6):641-58. PubMed ID: 22298469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.